Cyclacel Pharmaceuticals, Inc.
Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CYCC · as of Sep 30, 2025
Ownership Breakdown
6
Institutional Holders
▼ 8 vs Q2
$5,522
Total Inst. Value
▼ $103,100 vs Q2
1.67M
Shares Outstanding
freeFloat 95.10%
1,117
13F Shares Held
▼ 330,708 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CYCC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 1.1K | 5.59% | 5.59% | $5.29M | Nov 14, 2025 | NEW |
UBS GROUP AG pharmaceutical preparations | 40 | 0.21% | 0.21% | $198,000 | Nov 13, 2025 | NEW |
SBI SECURITIES CO., LTD. pharmaceutical preparations | 3 | 0.02% | 0.02% | $15,000 | Nov 5, 2025 | ▼ 72 |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 2 | 0.01% | 0.01% | $10,000 | Feb 3, 2026 | NEW |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 1 | 0.01% | 0.01% | $8,000 | Nov 14, 2025 | NEW |
ARCHER INVESTMENT CORP pharmaceutical preparations | 1 | 0.01% | 0.01% | $5,000 | Nov 3, 2025 | NEW |
HRT FINANCIAL LP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2025 | EXIT |
TOWER RESEARCH CAPITAL LLC (TRC) pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2025 | EXIT |
UBS GROUP AG pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
ARCHER INVESTMENT CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 3, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares5
New Positions
first time holders1
Decreased
−72 shares12
Sold Out
fully exitedNet shares change (top 50)
72
+0 / −72
Net new holders
-8
5 new / 12 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CYCC insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
4
Sell transactions
0.75
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Kua Khai Loon 10 percent owner | Sep 5, 2025 | Sale | 19,054 | $7.01 | $133.6K | 385.4K | Form 4 ↗ |
Yap Kim Choy 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | — | — | 404.5K | Form 4 ↗ |
Yap Kim Choy 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | $10.20 | $1.90M | 31.5K | Form 4 ↗ |
Kua Khai Loon 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | — | — | 404.5K | Form 4 ↗ |
Kua Khai Loon 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | $10.20 | $1.90M | 31.5K | Form 4 ↗ |
Ong Yee Lung 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | — | — | 404.5K | Form 4 ↗ |
Ong Yee Lung 10 percent owner | Sep 4, 2025 | J-Other | 186,465 | $10.20 | $1.90M | 31.5K | Form 4 ↗ |
Lazar David E. 10 percent owner | Jul 30, 2025 | Sale | 6,750 | $12.36 | $83.4K | 155.8K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cyclacel Pharmaceuticals, Inc. (CYCC) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 4.90%, while retail and public investors account for the remaining 95.03%.
The largest institutional shareholder of Cyclacel Pharmaceuticals, Inc. is TOWER RESEARCH CAPITAL LLC (TRC), holding approximately 1,070 shares — equal to 5.59% of outstanding shares — as of September 30, 2025.
A total of 6 institutional investors currently hold CYCC stock, with a combined institutional value of approximately $5,522 as of the most recent 13F filing period.
Frequently asked questions
CYCC ownershipCyclacel Pharmaceuticals, Inc. (CYCC) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is TOWER RESEARCH CAPITAL LLC (TRC) with a 5.59% stake. Company insiders hold 4.90%. Data sourced from SEC Form 13F as of September 30, 2025.